The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weekes, M. P.
Right arrow Articles by Carmichael, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weekes, M. P.
Right arrow Articles by Carmichael, A. J.
The Journal of Immunology, 2004, 173: 5843-5851.
Copyright © 2004 by The American Association of Immunologists

Long-Term Stable Expanded Human CD4+ T Cell Clones Specific for Human Cytomegalovirus Are Distributed in Both CD45RAhigh and CD45ROhigh Populations1

Michael P. Weekes, Mark R. Wills, J. G. Patrick Sissons and Andrew J. Carmichael2

Department of Medicine, University of Cambridge Clinical School, Cambridge, United Kingdom

T cells play an important role in the control of human CMV (HCMV) infection. Peripheral blood CD4+ T cell proliferative responses to the HCMV lower tegument protein pp65 have been detected in most healthy HCMV carriers. To analyze the clonal composition of the CD4+ T cell response against HCMV pp65, we characterized three MHC class II-restricted peptide epitopes within pp65 in virus carriers. In limiting dilution analysis, we observed high frequencies of pp65 peptide-specific CD4+ T cells, many of which expressed peptide-specific cytotoxicity in addition to IFN-{gamma} secretion. We analyzed the clonal composition of CD4+ T cells specific for defined HCMV peptides by generating multiple independent peptide-specific CD4+ clones and sequencing the TCR {beta}-chain. In a given carrier, most of the CD4+ clones specific for a defined pp65 peptide had identical TCR nucleotide sequences. We used clonotype oligonucleotide probing to quantify the size of individual peptide-specific CD4+ clones in whole PBMC and in purified subpopulations of CD45RAhighCD45ROlow and CD45RAlowCD45ROhigh cells. Individual CD4+ T cell clones could be large (0.3–1.5% of all CD4+ T cells in PBMC) and were stable over time. Cells of a single clone were distributed in both the CD45RAhigh and CD45ROhigh subpopulations. In one carrier, the virus-specific clone was especially abundant in the small CD28CD45RAhigh CD4+ T cell subpopulation. Our study demonstrates marked clonal expansion and phenotypic heterogeneity within daughter cells of a single virus-specific CD4+ T cell clone, which resembles that seen in the CD8+ T cell response against HCMV pp65.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. D. Walker, C. L. Maier, and J. S. Pober
Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes
J. Immunol., February 1, 2009; 182(3): 1548 - 1559.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Y. Takizawa, S. Inokuma, Y. Tanaka, K. Saito, T. Atsumi, M. Hirakata, H. Kameda, S. Hirohata, H. Kondo, S. Kumagai, et al.
Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population
Rheumatology, September 1, 2008; 47(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Stapler, E. D. Lee, S. A. Selvaraj, A. G. Evans, L. S. Kean, S. H. Speck, C. P. Larsen, and S. Gangappa
Expansion of Effector Memory TCR V{beta}4+CD8+ T Cells Is Associated with Latent Infection-Mediated Resistance to Transplantation Tolerance
J. Immunol., March 1, 2008; 180(5): 3190 - 3200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Vescovini, C. Biasini, F. F. Fagnoni, A. R. Telera, L. Zanlari, M. Pedrazzoni, L. Bucci, D. Monti, M. C. Medici, C. Chezzi, et al.
Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects
J. Immunol., September 15, 2007; 179(6): 4283 - 4291.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Delmas, P. Brousset, D. Clement, E. Le Roy, and J.-L. Davignon
Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells
J. Gen. Virol., September 1, 2007; 88(9): 2441 - 2449.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. N. Akbar and M. Vukmanovic-Stejic
Telomerase in T Lymphocytes: Use It and Lose It?
J. Immunol., June 1, 2007; 178(11): 6689 - 6694.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Fletcher, M. Vukmanovic-Stejic, P. J. Dunne, K. E. Birch, J. E. Cook, S. E. Jackson, M. Salmon, M. H. Rustin, and A. N. Akbar
Cytomegalovirus-Specific CD4+ T Cells in Healthy Carriers Are Continuously Driven to Replicative Exhaustion
J. Immunol., December 15, 2005; 175(12): 8218 - 8225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Amyes, A. J. McMichael, and M. F. C. Callan
Human CD4+ T Cells Are Predominantly Distributed among Six Phenotypically and Functionally Distinct Subsets
J. Immunol., November 1, 2005; 175(9): 5765 - 5773.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.